Hubei Hongyuan Pharmaceutical Technology 配当金
配当金 基準チェック /16
Hubei Hongyuan Pharmaceutical Technology is a dividend paying company with a current yield of 0.36% that is well covered by earnings.
主要情報
0.4%
配当利回り
0%
バイバック利回り
| 総株主利回り | 0.4% |
| 将来の配当利回り | n/a |
| 配当成長 | n/a |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | CN¥0.050 |
| 配当性向 | 74% |
最近の配当金アップデート
Recent updates
Subdued Growth No Barrier To Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SZSE:301246) With Shares Advancing 38%
Oct 08
Hubei Hongyuan Pharmaceutical Technology Co., Ltd.'s (SZSE:301246) P/S Still Appears To Be Reasonable
Aug 23Hubei Hongyuan Pharmaceutical Technology's (SZSE:301246) Soft Earnings Are Actually Better Than They Appear
Apr 29Getting In Cheap On Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SZSE:301246) Is Unlikely
Mar 14決済の安定と成長
配当データの取得
安定した配当: Too early to tell whether 301246's dividend payments have been stable as they only just started paying a dividend.
増加する配当: Too early to tell if 301246's dividend payments are increasing as they only just started paying a dividend.
配当利回り対市場
| Hubei Hongyuan Pharmaceutical Technology 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (301246) | 0.4% |
| 市場下位25% (CN) | 0.6% |
| 市場トップ25% (CN) | 2.2% |
| 業界平均 (Pharmaceuticals) | 1.7% |
| アナリスト予想 (301246) (最長3年) | n/a |
注目すべき配当: 301246's dividend (0.36%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.57%).
高配当: 301246's dividend (0.36%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
株主への利益配当
収益カバレッジ: With its reasonable payout ratio (73.9%), 301246's dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: 301246 is paying a dividend but the company has no free cash flows.